Zhang Zhehan 2025 New Era Launch: 'Scavenger' Concert is About to Begin

On November 16 last year, Zhang Zhehan’s "Primordial Theater" concert concluded successfully in Seoul, South Korea. From 2023 to 2024, Zhang Zhehan captivated tens of thousands of audiences with his music, vocals, and the power of "strength, persistence, and faith," touring through Bangkok (Thailand), Kuala Lumpur (Malaysia), Hong Kong (China), and more. On January 5 this year, Zhang Zhehan held a FANMEETING themed "yeah" in Hua Hin, Thailand. Four months later, his 2025 grand new show, the "Scavenger" concert, will take place on May 10, 2025, in Hong Kong, China, gathering all revelry and igniting sparks on stage. Tickets for this performance officially go on sale today (March 27), promising a musical feast filled with surprises and emotion! Zhang Zhehan’s "Scavenger" Look Revealed: Post-Apocalyptic Ambiance Sparks Anticipation The album Scavenger has already released six singles. Ahead of the full album’s launch, the concert themed "Scavenger" has been unveiled. Amidst swirling yellow sands and desolate wastelands, the "Scavenger" dons a cloak, standing solitary yet rooted deep into the earth’s core. Metallic tendrils burst from within, forging an unyielding heart immune to external pressures. This performance not only introduces a groundbreaking sci-fi "ruins" concept, traversing alien civilizations, but also debuts new singles from the album, custom-designed stage outfits, and dance crew aesthetics that embody post-apocalyptic beauty. An immersive experience will guide the audience into an elevated realm of imagination, delivering a dual feast for the eyes and ears. Tickets for Zhang Zhehan’s 2025 "Scavenger" Hong Kong concert go on sale March 27. Stay tuned! (https://www.fantopia.io/events-tickets?eventsKey=zzhhk25) Album Scavenger Gains Momentum Online Since the release of the first single Can You Hear Me in May last year, the album Scavenger has successively dropped six tracks: No Obstacles, Going Off, 90s, Farewell Slowly, and Lost in London, all achieving remarkable success. These songs frequently topped the iTunes Worldwide Song Chart and became radio favorites in Taiwan (China), Malaysia, and Singapore. Each song encapsulates Zhang Zhehan’s reflections and insights into diverse experiences, akin to precious treasures collected from life’s fragments. This concert will piece together these treasures and present them to the audience.

ForexEKO Revolutionizes Classic Candlestick Trading with AI Automation

Limassol, Cyprus – March 31, 2025 – (SeaPRwire) – Avenix Fzco announces the launch of ForexEKO, an AI-powered trading system that modernizes candlestick pattern analysis for precision trading. The trading world often talks about innovation, but some of the most effective strategies come from pairing old-school insights with modern technology. One of the clearest examples of this today is the revival of candlestick pattern trading, an age-old technique now getting a serious upgrade through automation and intelligent systems. At the center of this shift is ForexEKO, developed by Avenix Fzco, a trading system that brings new life to classic techniques using AI-driven pattern recognition and smart automation. Why Candlestick Patterns Still Matter Candlestick formations like the Hammer, Doji, and Engulfing have helped traders read market sentiment for decades. They tell a story about price movement – helping identify potential reversals or breakouts. But manually spotting these patterns takes time and experience, and even then, interpretation can vary. That’s where automated systems step in. Modern Tech, Classic Strategy ForexEKO enhances candlestick analysis by detecting and evaluating these formations using automated logic. This removes the guesswork, offering cleaner signals backed by historical data. By processing large datasets and eliminating inconsistencies in pattern recognition, ForexEKO helps traders make faster, more confident decisions. What Makes ForexEKO Stand Out Multi-Layered Trading Logic: ForexEKO doesn’t rely on candlesticks alone. It blends price action with indicators like Moving Averages and Oscillators to validate patterns and reduce false entries. Clear Risk Parameters: Every trade is secured with predefined Stop Loss and Take Profit levels. A global stop-loss mechanism adds extra protection, while a cautious martingale feature can assist in recovery without reckless exposure. Backed by Real Data: ForexEKO has been optimized using high-quality tick data from Thinkberry SRL’s Tick Data Suite. This ensures the system is based on real conditions – not assumptions. The result is a track record of stable performance, with simulations showing potential returns of up to 100% yearly from a $10,000 deposit, all while maintaining low drawdowns. Looking Ahead The integration of AI into traditional trading strategies like candlestick analysis signifies a broader shift towards more sophisticated and reliable trading tools. As AI continues to evolve, its ability to process vast amounts of data and identify subtle patterns will further enhance the precision of trading strategies, benefiting both novice and experienced traders.​ About ForexEKO ForexEKO is an Expert Advisor for MetaTrader 4, optimizing XAU/USD trading with advanced analysis and risk management. Designed for precision and consistency, it balances profitability with low drawdowns. Learn more at https://forexeko.com/. Media contact Brand: ForexEKO Contact: media team Email: support@forexeko.com Website: https://forexeko.com/

ForexIGO by Avenix Fzco Enhances Automated Trading with Dual-Asset Precision

Limassol, Cyprus – March 29, 2025 – (SeaPRwire) – Avenix Fzco has unveiled ForexIGO, an advanced multi-market trading bot designed to automate strategies for both gold (XAUUSD) and the British pound against the US dollar (GBPUSD), offering traders a streamlined approach to diversification. Automated trading has come a long way, versatility matters more than ever. Traders are increasingly looking beyond single-market bots and toward solutions that can handle multiple assets at once. This shift has sparked growing interest in multi-market trading bots – systems designed to navigate different markets simultaneously, spreading risk and boosting opportunity. One such tool is ForexIGO, developed by Avenix Fzco, which brings together smart automation for both gold (XAUUSD) and the British pound against the US dollar (GBPUSD). Why Multi-Market Trading Bots Are Gaining Ground Traditional trading bots often zeroed in on a single market or asset. Today, though, financial markets move fast and unpredictably, pushing the rise of bots that can handle multiple asset classes. This approach helps traders spread risk and seize opportunities across a wider landscape, less reliance on one market, more room to adapt. Dual-Asset Focus with Practical Precision ForexIGO is carefully crafted to trade both XAUUSD and GBPUSD on the M30 timeframe. This dual-asset focus gives traders the ability to shift between markets based on conditions or strategy, offering greater control and the potential for stronger returns. It’s a practical way to diversify without overcomplicating the process. How ForexIGO Makes It Work It stands out for its smart market analysis, decoding price action, indicators, and candlestick patterns like bullish or bearish engulfing to deliver clear, confident trade signals. Built-In Risk Controls for Real-World Markets Capital preservation remains central to ForexIGO’s strategy. Stop-loss and take-profit ratios are tailored to each market: for gold, the take profit is set at 1.5 times the stop loss, striking a thoughtful balance. For GBPUSD, it opts for a 1:1 ratio, tailored to the pair’s dynamics. This structured approach maximizes potential gains while keeping losses in check. Smart Limits and Continuous Monitoring To prevent overexposure, ForexIGO limits active positions, handling one gold position at a time and up to four concurrent GBP/USD trades. Its 24/5 monitoring ensures it remains alert across market sessions, offering consistent oversight without requiring the trader to be glued to a screen. Looking Ahead As traders move toward diversification and smarter automation, tools like ForexIGO offer a balanced, hands-on approach to navigating complex markets, without adding extra complexity. About ForexIGO ForexIGO delivers cutting-edge trading solutions, empowering traders to navigate the complexities of Gold and GBP/USD markets with precision. Backed by a team of market experts and algorithmic specialists, ForexIGO continuously evolves, leveraging innovation to provide a competitive edge. Learn more at https://forexigo.com/. Media contact Brand: ForexIGO Contact: PR team Email: support@forexigo.com Website: https://forexigo.com/

WiseChain.io Unveils AI-Powered Social Trading and Tailored Investment Solutions for Canadians and Seniors

New York, NY – March 29, 2025 – (SeaPRwire) – WiseChain.io, a global leader in next-generation trading technology, announces the launch of its cutting-edge AI-driven social trading platform, now available exclusively to its elite clients. This breakthrough solution enables users to mirror strategies of top-performing traders through advanced, automated bots — delivering precision, speed, and real-time adaptability. By integrating automation with artificial intelligence, WiseChain.io redefines the modern investing experience. The platform is ideal for both beginners and professionals, empowering users to benefit from expert-level trading without needing deep financial expertise. A Trusted Partner for Canadian Investors For Canadian clients, WiseChain.io offers a secure, fully compliant platform that operates under strict international standards. With rigorous KYC and AML protocols, segregated fund storage, and end-to-end encryption, users can trade confidently in a transparent and legally sound environment. Bilingual support in English and French, combined with access to a broad range of markets — including forex, crypto, stocks, commodities, and ETFs — positions WiseChain.io as a top choice for Canadian investors. Empowering Seniors Toward Financial Independence Understanding the needs of older investors, WiseChain.io also provides a user-friendly and low-risk environment tailored to individuals over 50. With step-by-step guidance, flexible strategies, and minimal commissions, seniors can easily manage their savings, build passive income, and secure a more comfortable retirement — even without prior trading experience. Thousands of users have already embraced WiseChain.io as their partner in financial growth, thanks to its intuitive design, 24/7 customer support, and clear educational resources. Discover the Future of Smart Investing Whether you’re a high-net-worth trader, a cautious retiree, or a Canadian investor looking for a reliable platform, WiseChain.io offers the tools, technology, and transparency to help you succeed. Visit wisechain.io to start your journey toward smarter, safer investing. Social Links Media Contact Brand: WiseChain Contact: media team Email: support@wisechain.io Website: https://wisechain.io

2025孤獨星球·星光跑:用愛點亮“星星的孩子”未來

海納特教集團助力孤獨星球·星光跑,共築自閉症兒童成長之路 Shenzhen, China - 2025年3月28日 - 由深圳市殘聯和龍華區人民政府指導,區殘工委主辦、區殘聯承辦的“孤獨星球·星光跑”公益活動將於3月30日上午在深圳龍華人才綠道群賢廣場正式開跑。本次活動旨在提升社會對自閉症群體的認知,推動社會各界共同為他們構建更加友好的成長環境。作為本次活動的主要協辦單位,深圳海納特教集團正積極籌備,號召自閉症兒童及家長、特教從業者和社會各界愛心人士踴躍參與。 孤獨症,又稱自閉症,是一種廣泛性發育障礙,主要表現為社交障礙、語言溝通困難和刻板行為模式。世界衛生組織(WHO)資料顯示,全球每100名兒童中就有1名被診斷為孤獨症。為提高公眾對這一群體的關注度,聯合國自2008年起將每年的4月2日設立為“世界自閉症關注日”。今年的孤獨星球·星光跑,正是為了在世界自閉症關注日前夕,通過運動和公益行動,讓更多人瞭解並接納自閉症群體。 攜手同行“孤獨星球·星光跑”,用愛點亮星光 本次星光跑活動,社會各界愛心人士和企業積極回應,踴躍報名參與並提供支持。活動將在3月30日早上7:30進行簽到和物資領取,並於8:30正式開跑。參與者將通過奔跑與陪伴,讓自閉症兒童及其家庭感受到社會的溫暖與關懷。 “我們希望不僅僅是為孤獨症兒童提供康復和教育服務,更要讓社會認識到,他們的成長和發展需要社會各界共同努力。”郭潔波先生補充道,“同時,我們也希望吸引更多投資者關注特殊兒童教育產業,這不僅具有重要的社會價值,也蘊藏著可持續發展的經濟潛力。” 未來,海納特教集團將持續深化在孤獨症康復教育領域的探索,為更多特殊兒童及其家庭帶去希望與改變。 關於中國自閉症兒童康復事業的可持續發展 近年來,中國自閉症兒童康復和教育行業逐步發展,社會關注度不斷提升。然而,行業仍面臨專業人才短缺、服務資源分佈不均、長期資金支持不足等挑戰。根據《中國自閉症教育康復行業發展狀況報告》,我國孤獨症群體已超過1000萬人,其中兒童超過200萬。 海納特教集團創始人郭潔波先生表示:“特殊兒童教育不僅是一項公益事業,更是具備長期可持續發展的社會產業。隨著社會認知的提升和政府政策的支持,行業正在從單一的康復培訓模式向‘康復+教育+就業’的多元化方向發展,為投資者提供了可觀的經濟回報。” 他進一步指出:“當前,社會資本的進入將加速行業的標準化和規模化,提升服務品質,同時推動技術創新,如智慧輔助康復設備、AI特教平臺等,使更多孤獨症兒童獲得更高效的成長支持。這不僅有助於解決社會問題,也能帶來穩定的長期收益。” 未來,隨著政府、社會組織及市場資本的共同推動,中國自閉症康復與教育行業將迎來更廣闊的發展前景,實現經濟效益與社會效益的雙贏。 構建自閉症兒童全生涯支持體系 海納特教集團創始人郭潔波先生表示:“孤獨症兒童被稱為‘星星的孩子’,他們的成長離不開社會的支持。海納希望通過此次星光跑活動,讓社會各界更加關注這一特殊群體,促進自閉症人士的社會融合。” 為了幫助孤獨症群體實現更好的發展,海納於2019年創辦了“海納星智夢工廠”,整合特教康復、職業培訓與就業支持,探索“康復教育+職前培訓+就業支持”的發展模式。在龍華區民政局的支持下,海納還註冊成立了深圳市龍華區海納兒童康復中心,為孤獨症兒童提供從學齡期到職前技能培訓、再到就業支援的全鏈條服務,助力他們更好地融入社會。 關於海納特教集團 海納特教集團成立於2009年,致力於為心智障礙者提供涵蓋早期干預、融合教育、職業培訓、支持性就業等在內的全生涯服務。截至目前,海納已為5000多名心智障礙人士提供支援,在深圳乃至整個大灣區享有良好聲譽。自2009年成立以來,海納不斷拓展服務體系,包括發育評估、早期康復、融合教育、職業技能培訓、支持性就業等,幫助孤獨症群體更好地融入社會,提升生活品質。瞭解更多,請關注http://hainatejiao.com/ 媒體聯絡 品牌:深圳海納特教集團 聯繫:媒體團隊 電話:(+86)18025411773 網站:http://hainatejiao.com/

Sonimedi Captivates the European Beauty Market – Wins ‘Best Hair Product’ Award at Cosmoprof Bologna 2025

A Breakthrough for K-Bio Beauty, Achieved Purely Through Product Excellence – Seoul, Korea – March 28, 2025 – (SeaPRwire) – Sonimedi (SONIMEDI) [Bio Cell Fusion Science Institute], a leader in K-bio beauty, has solidified its presence in the European beauty market by winning the ‘Best Hair Product’ Award at Cosmoprof Worldwide Bologna 2025, the world’s largest beauty trade show. The award-winning product, OVACO ProBio 6 Melanocell Shampoo, is a next-generation hair care innovation, featuring quadruple multi-function fusion technology, which integrates: Scalp balance maintenance with six probiotic complex ingredients UV-induced scalp damage protection through melanocyte activation Individually certified anti-hair loss functionality Restorative care for damaged hair OVACO first gained recognition as the signature program product in prestigious Spanish aesthetic salons. As word spread about its exceptional efficacy, demand surged across Europe—without the need for large-scale marketing campaigns. The product’s ability to meet the strict standards of European consumers purely through its quality has earned it the industry’s highest praise, with many calling it a “brand that speaks for itself.” The Sonimedi representative stated, “Our research has always been centered around humanity, life, and the intrinsic value of existence. This award proves that our commitment to authenticity resonates in the global market. We will continue to redefine the standards of K-bio beauty.” Recently, Sonimedi has expanded its consumer reach by launching a dedicated line of high-performance home beauty devices, including focused ultrasound, radiofrequency, and galvanic skincare solutions. Developed with years of R&D expertise, these products are already recognized as signature treatments in dermatology clinics and aesthetic salons worldwide. Currently, Sonimedi is advancing beyond functional cosmetics into the cutting-edge field of applied biocell beauty, leveraging stem cells, iPS cells, exosomes, peptides, and biomaterials. With a strong foundation in global ODM partnerships, the company is rapidly accelerating its expansion into the European, Middle Eastern, and Asian markets. Social Links Instagram: https://www.instagram.com/everyday_ovaco/  Media Contact Brand: SONIMEDI Co. Contact: Partners Team Email: wepartner@sonimedi.com  Website: https://www.ovaco.net/

Kristof Schöffling’s Move Digital Leads Global Tech Transformation in 2025 with Breakthroughs in AI, Blockchain, and Robotics

Mahe, Seychelles – March 27, 2025 – (SeaPRwire) – Move Digital Limited, led by tech entrepreneur and strategist Kristof Schöffling, has unveiled an ambitious roadmap for 2025, solidifying its position as a global leader in artificial intelligence, blockchain, and robotics innovation. With operations across Monaco, Thailand, Tokyo, Sydney, and Hong Kong, Move Digital is delivering on its mission to integrate advanced technology into daily life – long before mainstream adoption. A Vision for 2025 Built on Proven Execution Kristof Schöffling, a serial entrepreneur with over 15 years of experience and several successful tech exits, has developed a reputation for recognizing transformational trends before they become global movements. Under his leadership, Move Digital has evolved from a blockchain innovator into a world-class firm delivering AI-powered consumer applications, elite consulting for family offices, and cutting-edge robotics manufacturing. “Artificial intelligence should never be a concept locked in boardrooms or labs,” says Schöffling. “Our mission at Move Digital is to bring intelligent solutions into everyday lives, enabling convenience, freedom, and efficiency for all demographics.” AI for the Real World Move Digital’s AI division is now rolling out globally distributed applications that simplify daily routines, boost productivity, and enhance user experience across demographics. These solutions are designed to demystify AI and make its value tangible for businesses, households, and institutions. Strategic Consulting for Family Offices & Global Investors Recognizing a sharp uptick in demand for trusted tech advisors, Schöffling has expanded Move Digital’s footprint into strategic consulting for family offices and high-net-worth individuals. The firm now works with legacy investors in financial capitals such as Monaco, Tokyo, Bangkok, and Hong Kong – helping them navigate AI strategy, digital transformation, and blockchain innovation. “AI is no longer a playground for tech firms. It’s a fundamental economic asset,” says Schöffling. “Whether you’re overseeing a global portfolio or operating a legacy business, integrating AI is now a matter of staying competitive.” Robotics: Move Digital’s Next Frontier In 2025, Move Digital is entering the robotics space with production facilities under development in Vietnam and China. These facilities will produce intelligent household robots powered by modular AI systems and connected digital infrastructure. Forecasts project the global robotics market to grow from $46 billion in 2024 to over $169 billion by 2032. Move Digital aims to lead this charge with innovative products that bring automation into private homes and elevate the quality of daily living. Public Sector Engagement & Innovation In addition to his private sector success, Kristof Schöffling plays a key role in advising governments on emerging technology adoption. As Trade Commissioner of Vanuatu to Thailand, he contributes to initiatives around blockchain strategy and CBDC implementation – bridging public and private sector goals for a tech-driven future. About Kristof Schöffling Kristof Schöffling is a renowned technology leader, known for his early adoption of blockchain, AI, and decentralized systems. With a strategic footprint in Monaco, Thailand, and across Asia-Pacific, Schöffling is recognized globally for transforming emerging technology into high-impact solutions. Whether searched as Kristof Schöffling, Kristof Schoffling, or Kristof Schoeffling, his work consistently ranks among the most relevant and forward-looking in tech innovation. About Move Digital Limited Move Digital Limited is a global technology firm delivering AI-powered applications, high-end consulting for family offices, and robotics manufacturing focused on household automation. With a vision to make advanced technologies accessible, Move Digital continues to redefine the intersection of technology and real-world utility. Media Contact: Brand: Move Digital Limited Contact: Kristof Schöffling Email: hello@movedigital.io Website: https://movedigital.com

Mastery Made Easy: A First Look at HIKMICRO’s New Devices at JAGD & HUND 2025

Dortmund, Germany – March 26, 2025 – (SeaPRwire) – HIKMICRO, a pioneering optics manufacturer, is set to unveil two groundbreaking thermal monoculars at JAGD & HUND Dortmund 2025, reinforcing its commitment to innovation in hunting technology. The FALCON 2.0 and CONDOR LRF 2.0 will be showcased at Germany’s Messe Dortmund from January 28 to February 2, 2025, embodying the company’s “Mastery Made Easy” philosophy. These new devices represent a significant leap forward in thermal hunting technology, focusing on one-handed operation and superior image quality. The FALCON 2.0 and CONDOR LRF 2.0 feature a highly sensitive 15mK thermal detector, capturing minute temperature differences and providing rich image details on a 0.49″ display. Both models offer precise laser rangefinding capabilities up to 1000 meters and incorporate HIKMICRO’s Shutterless Image System (HSIS) for continuous, uninterrupted viewing. Mr. Wang, HIKMICRO’s R&D expert, stated, “We have made comprehensive improvements to the FALCON and CONDOR models with ‘Mastery Performance’ and ‘One-handed, easy operation’ functions. We made these advancements while maintaining high image quality to provide the most comfortable observation, with usability enhancements delivering a simplified and intuitive operating experience.” The thermal monoculars boast an optimized 21700 battery, providing over six hours of operation time, and are compatible with external power banks. Both models feature a rear focus wheel and inline button arrangement for intuitive one-handed use, catering to hunters of all ages and handedness preferences. HIKMICRO equips the CONDOR LRF 2.0 series with an integral laser rangefinder and sculpts it to cradle the hand. Meanwhile, the FALCON 2.0 maintains a traditional cylindrical shape, and the FQ50L 2.0 model features an in-lens LRF module design. These ergonomic designs guarantee comfortable operation and reduced fatigue during extended use. Its commitment to user-centered innovation is evident in the development process of these thermal monoculars. The company conducted extensive market research and rigorous testing, including sending prototypes to professional hunters for real-life scenario evaluations. This meticulous method certifies that the final products meet the highest performance and usability standards. The new thermal monoculars also offer enhanced connectivity through the HIKMICRO Sight App, allowing users to live-view, browse and save captured images and videos, share with friends, upgrade products, and track after-sales information. This feature enhances the overall hunting experience and fosters a sense of community among users. Stefan Li, the company’s overseas director, emphasized the company’s vision: “We aim to keep blazing the trail by creating more precise, faster, and easier ways to help hunters master the mystery of the night. Our new FALCON 2.0 and CONDOR LRF 2.0 are testament to this commitment, providing hunters with the tools they need to enhance their skills and enjoy their passion to the fullest.“ As HIKMICRO prepares to showcase these innovative devices at JAGD & HUND Dortmund 2025, the company continues to push the boundaries of thermal hunting technology while respecting traditional hunting values and expert craftsmanship. About HIKMICRO HIKMICRO is a world-leading optics brand committed to “Continually Make Crafted Confidence” for hunters. The company focuses on user-centered innovation, pushing the boundaries of technological performance while respecting traditional hunting values and expert craftsmanship. With a dedication to providing mastery solutions, HIKMICRO aims to make hunting easier and more rewarding for enthusiasts around the globe. Contact Information Contact: Lina Wang Brand: HIKMICRO Email Address: wanglina21@hikmicrotech.com Website: https://www.hikmicrotech.com/en/

Mastery Made Easy: HIKMICRO’s New FALCON 2.0 and CONDOR LRF 2.0 Introduced at the JAGD & HUND 2025

DORTMUND, Germany – March 25, 2025 – (SeaPRwire) – HIKMICRO, a leading optics manufacturer, will unveil its latest thermal hunting innovations, the FALCON 2.0 and CONDOR LRF 2.0 thermal monoculars, at JAGD & HUND Dortmund 2025. The event, taking place from January 28 to February 2 at Messe Dortmund, will showcase these groundbreaking devices that embody the company’s “Mastery Made Easy” philosophy. The FALCON 2.0 and CONDOR LRF 2.0 represent significant advancements in thermal imaging technology, focusing on one-handed operation and superior image quality. These devices feature a highly sensitive 15mK thermal detector, capturing minute temperature differences and providing rich image details on a 0.49″ display. The CONDOR LRF 2.0 series features an integral laser rangefinder and has an ergonomic design that cradles the hand. Meanwhile, the FALCON 2.0 maintains a traditional cylindrical shape. Mr. Wang, HIKMICRO’s R&D expert, stated, “We have made comprehensive improvements to the FALCON and CONDOR models with ‘Mastery Performance’ and ‘One-handed, easy operation’ functions. We have made these advancements while maintaining high image quality to provide the most comfortable observation. The enhanced usability will deliver a simplified and intuitive operating experience.” Both models incorporate HIKMICRO’s Shutterless Image System (HSIS), eliminating image freeze and guaranteeing continuous, smooth viewing. The devices boast an optimized 21700 battery, offering over six hours of operation time, and are compatible with external power banks for extended use. The laser rangefinder function can precisely determine ranges up to 1000m (±1m), enhancing shot placement accuracy for safe and humane hunting. The new models feature a rear focus wheel and inline button arrangement, certifying intuitive operation for hunters of all ages. The devices offer multiple carrying options, including a neck strap, wrist lanyard, and monocular carrying bag, catering to various hunting styles and preferences. Stefan Li, HIKMICRO’s overseas director, emphasized the company’s commitment to innovation, stating, “HIKMICRO’s vision is to keep blazing the trail by creating more precise, faster and easier ways to help hunters master the mystery of the night. These new devices reflect our dedication to user-centered innovation and understanding hunters’ needs in the field.” About HIKMICRO HIKMICRO is a world-leading optics brand dedicated to “Continually Make Crafted Confidence” for hunters. The company focuses on user-centered innovation, combining technological breakthroughs with traditional hunting values and expert craftsmanship to deliver superior hunting experiences. Contact Information Brand: HIKMICRO Contact: Lina Wang Email: wanglina21@hikmicrotech.com Website: https://www.hikmicrotech.com/en/

RoadRunner Auto Transport Unveils Instant Car Shipping Quotes to Meet Rising Consumer Demand for Instant, Transparent Pricing

New York, NY – March 24, 2025 – (SeaPRwire) – RoadRunner Auto Transport, a leader in the vehicle shipping industry, is addressing the increasing consumer demand for faster, more accurate car transport pricing by launching its innovative instant car shipping quote tool. This move reflects the company’s commitment to improving customer experience in the auto transport sector by providing instant, transparent pricing for vehicle shipments across the country. As e-commerce and online shopping have set new standards for immediate service, consumers now expect the same speed and clarity in other sectors, including auto transport. In response to these expectations, RoadRunner Auto Transport has introduced an instant car shipping quote tool designed to offer instant pricing and carrier availability. The tool allows customers to receive accurate car shipping estimates based on their specific requirements, including route, pick-up times, and delivery windows. With the growth of online shopping, consumers now expect fast, reliable services, including in industries such as auto transport. Instant and accurate quotes offer a crucial solution for those needing quick decisions on vehicle shipping, eliminating the traditional waiting periods for manual estimates. According to RoadRunner Auto Transport, the company has seen a marked increase in the use of its instant car shipping calculator, indicating a growing consumer preference for immediate and transparent pricing. Why Instant Quotes Are Essential for the Auto Transport Industry The demand for faster shipping solutions has expanded beyond just traditional delivery services to include car transport. Instant quotes are now essential for consumers making time-sensitive decisions. With the new tool from RoadRunner Auto Transport, customers can access instant price calculations that reflect the most up-to-date data, ensuring they are informed before committing to a shipping service. In addition to speed and transparency, the Instant calculator offers flexibility, allowing customers to choose from multiple shipping routes and options based on the latest information, including potential weather delays, road closures, and fluctuating fuel prices. These features are crucial as car transport often involves complex logistical considerations. “As transportation networks continue to evolve, we’re committed to leveraging technology to provide the best customer experience possible,” said a spokesperson for RoadRunner Auto Transport. “Our instant shipping calculator is one way we’re helping customers make informed decisions quickly and with confidence.” Meeting the Growing Expectations for Transparency and Speed Historically, consumers had to wait hours or even days for manual pricing estimates. The introduction of instant auto shipping quotes addresses this outdated model, providing instant access to car shipping prices and offering transparency in ways that weren’t possible before. RoadRunner Auto Transport’s instant tool is quickly becoming the industry standard, transforming the way customers plan and book car transport services. “Today’s customers expect fast, accurate, and reliable information when it comes to shipping their vehicles. Our Instant shipping calculator delivers price quotes within seconds, eliminating the uncertainty and delays that used to be commonplace in the industry,” the company spokesperson added. The Future of Instant Shipping in Auto Transport The introduction of the instant car shipping calculator is more than just a temporary trend; it is a response to evolving consumer needs. As more customers demand instant access to information, the auto transport industry is expected to continue embracing technology to enhance customer service. RoadRunner Auto Transport is at the forefront of this change, providing cutting-edge tools like the car shipping calculator to meet growing demand for speed, accuracy, and transparency. Looking ahead, industry experts predict that instant quoting will become an integral part of the vehicle shipping process. With continuous advancements in technology, auto transport companies are poised to offer even more customized solutions that will streamline the shipping experience, all while maintaining the high standards of service that today’s consumers expect. For more information, call (888) 777-2123. For Media Inquiries: Brand: RoadRunner Auto Transport Contact: Media team Email: info@roadrunnerautotransport.com Website: https://www.roadrunnerautotransport.com

SeaPRwire Introduces Intelligent News Push System for Personalized Press Release Distribution

Hong Kong – March 24, 2025 – SeaPRwire, a leading Public Relations Communication Platform in Asia, has announced the integration of an innovative Intelligent News Push System into its service offerings. This new system, powered by Asia Presswire, aims to revolutionize how press releases are distributed by personalizing the delivery process based on users’ interests and reading history. The Intelligent News Push System leverages artificial intelligence (AI) and machine learning (ML) algorithms to tailor news content recommendations. By analyzing user preferences and behaviors, the system provides news platforms and social media Key Opinion Leaders (KOLs) with highly relevant and personalized press release suggestions. This approach enhances the chances of reaching the right audience and maximizes the impact of communications efforts. “With the integration of this AI-driven solution, SeaPRwire is taking a major step forward in delivering more targeted and effective communication strategies for our clients,” said Jane Woo, Product Director at SeaPRwire. “By utilizing the latest in machine learning technology, we are able to offer a personalized experience that not only improves audience engagement but also helps brands achieve greater visibility and influence across diverse media platforms.” The system’s ability to track and analyze user interactions, such as reading habits and engagement patterns, ensures that each press release reaches the most relevant journalists, editors, and influencers. This level of customization allows for a more efficient distribution process, reducing noise and ensuring that the right content gets into the hands of those who are most likely to share or report on it. In addition to its AI-powered features, the Intelligent News Push System can measure the effectiveness of each press release by analyzing engagement data, providing valuable insights into how content is performing across different channels. This helps brands fine-tune their communications strategy for optimal results. SeaPRwire’s new system is designed to serve clients across the Asia-Pacific region, including Japan, China, Korea, Hong Kong, Singapore, Vietnam, Thailand, Malaysia, Indonesia, and the Philippines. With a network that spans over 80,000 journalists and 300 million KOL followers, SeaPRwire continues to build on its reputation as a leading platform for earned media communications management. The collaboration with Asia Presswire brings cutting-edge technology to the platform, making SeaPRwire a more powerful tool for PR and communication professionals looking to enhance their brand presence in the region. This strategic development reinforces SeaPRwire’s commitment to providing innovative, data-driven solutions that meet the evolving needs of the modern communications landscape. By focusing on personalization and AI-driven strategies, SeaPRwire is poised to transform how press releases are distributed, ensuring that brands can connect with the right audiences at the right time. About Asia Presswire Asia Presswire is a press release distribution service that provides tailored solutions for public relations firms, agencies, organizations, and corporations worldwide. They specialize in delivering customized press release distribution, including direct-to-editor email delivery to targeted media editors at newspapers, magazines, and broadcast outlets. Their extensive network spans 172 countries, connecting with over 230,000 media outlets and 3.6 million self-media platforms. Supporting over 46 languages, including English, Chinese, French, German, and Japanese, Asia Presswire ensures effective communication across diverse linguistic regions. Their services are designed to enhance brands’ online visibility and reputation, enabling effective connection with target audiences. About SeaPRwire SeaPRwire is a leading earned media communications management platform in Asia, designed to empower PR and communications professionals. Its Branding-Insight Program streamlines communication management by connecting clients with a network of over 80,000 journalists, editors, magazines, and online media outlets, along with 300 million followers of key opinion leaders (KOLs). Leveraging AI-driven technology, SeaPRwire enables users to identify relevant media and KOLs, personalize pitches, and measure the impact of their communications efforts. Operating across regions including Japan, China, Korea, Hong Kong, Singapore, Vietnam, Thailand, Malaysia, Indonesia, and the Philippines, SeaPRwire enhances brand awareness and educates audiences effectively. Media Contact Brand: SeaPRwire Contact: Media team Email: cs@seaprwire.com Website: https://seaprwire.com

SeaPRwire引入智能新聞推送系統,實現個性化新聞稿投放

香港 - 2025年3月24日 - SeaPRwire,亞洲領先的新聞發佈管理平臺,宣佈將創新的智能新聞推送系統引入其服務。該系統由Asia Presswire提供技術支持,旨在通過根據用戶興趣和閱讀歷史個性化新聞稿投放,徹底改變新聞稿的分發方式。 智能新聞推送系統利用人工智慧(AI)和機器學習(ML)演算法,根據用戶的偏好和行為量身定制新聞內容推薦。通過分析用戶的興趣和閱讀模式,系統向新聞平臺和社交媒體關鍵意見領袖(KOL)提供高度相關和個性化的新聞稿建議。這種方法增強了觸及目標受眾的機會,並最大化了傳播效果。 "通過整合這一基於AI的解決方案,SeaPRwire在為客戶提供更具針對性和更有效的傳播策略方面邁出了重要一步,"SeaPRwire產品總監Jane Woo表示。"利用最新的機器學習技術,我們能夠提供個性化的體驗,不僅提升了受眾互動,還幫助品牌在多樣化媒體平臺上獲得更大的曝光和影響力。" 該系統能夠追蹤和分析用戶互動,如閱讀習慣和參與模式,確保每份新聞稿都能觸及最相關的記者、編輯和影響者。這種定制化水準提高了分發效率,減少了冗餘資訊,確保相關內容能夠到達最有可能分享或報導的人群手中。 除了AI驅動的功能外,智能新聞推送系統還可以通過分析參與數據來衡量每篇新聞稿的效果,提供有價值的洞察,幫助品牌瞭解內容在不同管道的表現。這有助於品牌優化其傳播策略,達到最佳效果。 SeaPRwire的這一新系統旨在服務亞洲及太平洋地區的客戶,包括日本、中國、韓國、香港、新加坡、越南、泰國、馬來西亞、印尼和菲律賓。憑藉覆蓋超過80,000名記者和3億KOL粉絲的網路,SeaPRwire繼續鞏固其作為領先的新聞傳播平臺的地位。 與Asia Presswire的合作為平臺引入了最前沿的技術,使SeaPRwire成為PR和通訊專業人士在該地區提升品牌影響力的強大工具。 這一戰略性的發展再次彰顯了SeaPRwire致力於提供創新、數據驅動解決方案的承諾,滿足現代通訊領域日益變化的需求。通過專注於個性化和AI驅動的策略,SeaPRwire有望徹底改變新聞稿的投放方式,確保品牌能夠在正確的時間觸及到正確的受眾。 關於Asia Presswire   Asia Presswire是一家新聞稿發佈服務公司,為全球公關公司、代理機構、組織和企業提供定制化解決方案。他們專注於提供定制化的新聞稿分發服務,包括通過電子郵件直接發送新聞稿給報紙、雜誌和廣播媒體編輯。其廣泛的網路覆蓋172個國家,連接超過230,000個媒體管道以及360萬個自媒體平臺。Asia Presswire支持超過46種語言,包括英語、中文、法語、德語和日語,確保在多語言區域內實現有效溝通。其服務旨在提升品牌的線上可見性和聲譽,有效地與目標受眾建立聯繫。 關於SeaPRwire   SeaPRwire是亞洲領先的媒體傳播管理平臺,旨在賦能公關和傳播專業人士。其品牌洞察計畫通過將客戶與80,000多名記者、編輯、雜誌和線上媒體平臺連接,簡化了傳播管理,同時還與3億多關鍵意見領袖(KOL)粉絲網路對接。借助AI技術,SeaPRwire幫助用戶識別相關媒體和KOL,個性化推介內容,並衡量傳播效果。SeaPRwire在包括日本、中國、韓國、香港、新加坡、越南、泰國、馬來西亞、印尼和菲律賓等地區運營,有效提升品牌認知並教育受眾。 媒體聯繫 Brand: SeaPRwire Contact: Media team Email: cs@seaprwire.com Website: https://seaprwire.com

China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum

SHENZHEN, Mar 21, 2025 – (ACN Newswire) – On March 17, China Medical System Holdings Limited (“CMS” or the “Company”) released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. Profit for the year was RMB1,613 million, and normalized profit for the year that excluding the provisions of impairment losses on related assets was RMB 1,714 million. The results announcement shows that in 2024, the performance decline of the Company was mainly influenced by the implementation of the National Volume Based Procurement (the “National VBP”), resulting in a year-on-year turnover (in the case that all medicines were directly sold by the Company) decrease of 28.8% to RMB2,691 million for three original drugs that were not selected. However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term pains, the development of exclusive and innovative drugs has many highlights and their potential has begun to emerge. In 2024, in the case that all medicines were directly sold by the Company, the turnover of exclusive and innovative products was RMB4,551 million, representing a year-on-year increase of 4.1%, accounting for 52.8% of the total turnover. This year, the Company has cumulatively had 5 innovative drugs enter into commercialization, but they were all in the early market introduction stage. In the future, as the marketed innovative drugs gradually expand into large-scale clinical applications and their sales ramp up rapidly, and as the quality innovative pipeline continues to be approved for marketing, the Company will enter a new cycle of quality and sustainable development driven by exclusive and innovative drugs. According to the announcement, in 2024, CMS submitted the NDAs for two novel drugs in China, including the innovative drug for the vitiligo treatment, ruxolitinib cream, established three innovative drug collaborations and three medical aesthetic product collaborations. As of the end of 2024, the Company has accumulated a total of nearly 40 short-term, medium-term, and long-term innovative pipeline products. In addition, the Company’s Southeast Asia business is poised for takeoff. This year, it has promoted more than five innovative drugs to submit market registration applications. The preparatory work for the Singapore factory of the associated company has been basically completed, and it is about to fully launch pharmaceutical CDMO and sales promotion businesses, cultivating a second growth curve. Product Competitiveness as the Core to Solidify the Innovation Growth Engine As a pharmaceutical commercialization leader with over three decades of experience in the pharmaceutical market and having promoted multiple marketed drugs to achieve leading market positions, CMS also maintains a keen market insight when deploying innovative drugs. It selects global FIC (First-in-Class) and BIC (Best-in-Class) innovative drugs based on front-line market demands, adhering to the “three-good-variety” screening criterias: having academic differentiated advantages, significant market potential and good competitive landscape, and high comprehensive return on investment. Looking at the Company’s marketed innovative drugs, the five products either have clear differentiation advantages compared to the existing products in the market or fill market gaps in particular areas. Therefore, they can provide valuable innovative treatment options for patients. For example, VELPHORO (Sucroferric Oxyhydroxide Chewable Tablets), used for phosphorus reduction in chronic kidney disease (CKD) patients, is the first iron-based, non-calcium phosphate binder (PB) approved by China’s NMPA, and filled the gap of phosphorus-lowering treatment for Chinese paediatric patients aged 12 to 18 years old with CKD stages 4-5 or CKD on dialysis. According to multiple global clinical studies and real-world research data (as published in academic journals including International Urology and Nephrology, and Clinical Nephrology) and the Chinese instruction of the product that compared with other PBs, patients maintained on VELPHORO used about 50% fewer PB pills/day, and a proportion of patients achieving target sP increased by 95%. ILUMETRI (Tildrakizumab Injection) is an innovative biological agent targeting to the p19 subunit of IL-23 for the treatment of moderate-to-severe plaque psoriasis. It only requires dosing once every three months during the maintenance period. With its excellent long-term efficacy, convenient dosing cycle, and good safety profile, the patient compliance is improved. With the excellent product strength as the core and leveraging the rich academic resources and promotional experience accumulated over the years, the Company is expected to rapidly enhance the market penetration and brand influence of its marketed products. The Company’s two innovative drugs, ruxolitinib cream and Desidustat Tablets, which are, currently in the NDA review stage in China and expected to be launched in 2025, are both considered to have good market potential. According to the announcement, ruxolitinib cream is the first and only topical JAK inhibitor approved by the U.S. FDA and the European EMA for repigmentation in vitiligo as of now. If successfully approved for marketing, it will bring treatment hopes to more than ten million vitiligo patients in China who are suffering from the lack of effective drugs. Desidustat Tablets are used for treating anemia in non-dialysis adult, CKD patients and are administered orally. Its Chinese Phase III clinical trial shows that it performs well in efficacy, safety, and tolerability. Data shows that there are approximately 132 million CKD patients in China, and anemia is one of the frequent complications. After approved for marketing, the product is expected to further meet the anemia treatment needs of CKD patients. In addition, among the innovative pipeline products that the Company has reserved and are expected to be approved for marketing within the next 2 to 4 years, there are also several products with high market attention and industry-assessed potential to become FIC and BIC blockbuster drugs, such as Y-3 for stroke treatment, the highly selective small-molecule oral JAK1 inhibitor povorcitinib (for non-segmental vitiligo and hidradenitis suppurativa), the URAT1 inhibitor ABP-671 (for gout), the anti-IL-4Rα humanized monoclonal antibody injection MG-K10 (for atopic dermatitis), the oral improved new drug ZUNVEYL (for Alzheimer’s disease), etc. These products will strongly support the Company’s continuous growth in future performance. Notably, CMS has always adhered to an efficient innovation strategy of “Collaborative R&D and In-house R&D” and attached great importance to maximizing the efficiency of R&D investment. From 2018 to 2024, the Company recorded cumulatively R&D expenditures of around RMB4,350 million, accounting for 7.6% of the turnover during the same period in the case that all medicines were directly sold by the Company, of which the R&D expenses were RMB880 million, accounting for 1.5% of the turnover during the same period in the case that all medicines were directly sold by the Company. Through relatively prudent R&D investment, the Company has successfully realized the project initiation, clinical development, and marketing of several quality innovative products, achieving extremely high innovation input-output efficiency. In addition, as of the end of 2024, the cash and bank deposit recorded RMB3,707 million, sufficiently safeguarding the continuous innovation and in-depth exploration of cutting-edge fields. Refining the Commercialization System Focused on Specialty to Empower the Release of Product Value The synergy between strong product power and efficient commercialization capabilities is the key to maintain the competitive advantage of the Company. CMS continuously upgrades its specialty-focused commercialization system, and forms an in-depth layout focusing on core specialties of cardio-cerebrovascular/gastroenterology, dermatology/medical aesthetics, and ophthalmology. Leveraging its accumulated extensive professional promotion networks and academic platforms, CMS will safeguard the successful commercialization of innovative products. Since its independent operation in 2021, “CMS Skinhealth”, is developing into a “leading, innovation-driven pharmaceutical company in China, specializing in skin health”. CMS Skinhealth has formed a comprehensive product portfolio centered on dermatology prescription drugs and extended to dermatology-grade skincare products and light medical aesthetic products. As of the end of 2024, the dermatology prescription portfolio of CMS Skinhealth has comprehensively covered dermatology diseases, such as vitiligo, psoriasis, atopic dermatitis, phlebitis, varicose veins, and hidradenitis suppurativa. As for dermatology-grade skincare products, the “Heling Soothing Product Series”, which are dedicated to sensitive skin care, have been further perfected. The Hirudoid® Azelaic Acid Skincare Series has been newly launched to provide a comprehensive acne-care solution. In the field of light medical aesthetic, the registration application of Poly-L-lactic Acid Microparticle Filler Injection in China has been accepted. Additionally, the Company has introduced three regenerative products, Polycaprolactone Microsphere Gel for Injection, Calcium Hydroxylapatite Microsphere Gel for Injection, and Decellularized Extracellular Matrix Implant, which are currently under the registrational clinical trial stages in China, further enhancing the light medical aesthetic product portfolio. CMS Skinhealth offers a diverse matrix of dermatological health and aesthetic products, providing comprehensive and integrated solutions to individuals with varying needs for skin health and beauty. Concurrently, “CMS Vision”, an independently operated ophthalmology business, focuses on the development and commercialization of ophthalmic prescription drugs, medical devices, and consumables. In China, a large number of patients suffer from ophthalmic diseases, and the burden of ophthalmic diseases is increasing significantly due to the population growth and aging. Leveraging on professional ophthalmic product portfolio, extensive network and channel resources, CMS Vision continuously strengthens its brand strength and academic position, aspiring to become a leading ophthalmic pharmaceutical and device company in China. As of the end of 2024, CMS had approximately 4,700 professional marketing and promotion related employees, with a promotion network covering over 50,000 hospitals and medical institutions, and approximately 300,000 retail pharmacies in China. Leveraging its efficient marketing and promotion team along with an extensive promotion network, the Company focuses on the marketed innovative drugs and core exclusive products, dynamically optimizes the marketing strategy, initiates real-world studies and post-marketing clinical trials, continuously accumulates academic evidence, strengthens the products academic influence, and accelerates the transformation into market value. Simultaneously, the Company has strengthened its expansion in the breadth and depth of coverage in the out-of-hospital market. Through integrated online and offline strategies and multi-channel collaboration, it has achieved a dual improvement in the out-of-hospital prescription traffic diversion and patient benefits. Starting with Southeast Asia and Cultivating the Second Growth Curve of Overseas Business While deeply developing in the Chinese market, CMS is also accelerating its pace of internationalization. Starting with Southeast Asia and leveraging the favorable opportunity of the rapidly growing local demand for high cost-effective pharmaceutical products, the Company is actively nurturing the growth engine of its overseas business, injecting new momentum into its long-term and sustainable development. In 2024, the Southeast Asia business, Rxilient Health, focusing on regional characteristics and disease spectrum features, executed a precise planning of its product portfolio and commercial pathways, and achieved notable milestones in the marketing registration for multiple products, laying the foundation for future market promotion and the realization of sales. Within this year, Rxilient Health has obtained the exclusive licenses in eleven Southeast Asian countries for povorcitinib, a selective small-molecule JAK1 Inhibitor, with the potential to provide a new treatment option for patients with autoimmune and inflammatory skin diseases. Meanwhile, Rxilient Health is actively advancing the registration of several innovative products in Southeast Asia, and/or in Hong Kong, Macau, and Taiwan, including ruxolitinib cream, ILUMETRI, LUMEBLUE, VALTOCO, VELPHORO and so on. Among them, ruxolitinib cream has been approved for marketing in Macau and Hong Kong for the treatment of vitiligo, and also submitted the registration applications in Singapore and Taiwan. Additionally, intravenous toripalimab (anti-PD-1 monoclonal antibody drug), collaborated by Rxilient Health and Junshi Biosciences, has submitted registration applications in Malaysia, the Philippines, Indonesia, Thailand, and Vietnam. Regarding the CDMO business, the associate company PharmaGend’s manufacturing plant in Tuas, Singapore has received the U.S. FDA GMP certification and successfully passed an on-site inspection by the Singapore HSA. It will provide CDMO services to global pharmaceutical companies and play a critical role in ensuring the safety of the Company’s overseas manufacturing supply chain. At the outset of a new journey, CMS proactively adapts to change and strides toward innovation, steadfastly executes the strategy of “innovation-driven, efficiency -priority, specialty breakthrough, and international expansion”. By reshaping the growth curve and cultivating a more diversified and resilient business framework, the Company is advancing into a new phase of quality development, providing patients with more quality therapeutic options while generating long-term stable returns for shareholders. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd.

The 33rd China International Bicycle Fair 2025 Set to Grandly Open

Shanghai, China – March 21, 2025 – (SeaPRwire) – One of the most influential events in the global bicycle industry, the 33rd China International Bicycle Fair (China Cycle 2025), will be held from May 5-8, 2025, at the Shanghai New International Expo Centre (SNIEC), China. Under the theme “Empowering Innovation, Sharing the Future”, the exhibition will bring together industry leaders from around the world to explore new opportunities for innovation and collaboration. As a barometer of the global bicycle industry, China Cycle has successfully held over thirty editions, continuously expanding in scale and influence. In 2024, the exhibition covered 150,000 m2, attracting 1,460 exhibitors and nearly 200,000 visitors from 137 countries and regions. China Cycle 2025 is set to elevate the event further with an expanded platform, optimized layout, and enhanced services, showcasing the latest technologies, products, and market trends in the global bicycle and e-bike sector. With the global bicycle industry on a recovery path, China’s bicycle sector is experiencing particularly strong growth, bringing renewed confidence to the industry. China Cycle 2025 will stay aligned with industry trends by expanding exhibition space, optimizing the event structure, and facilitating deeper integration of the global supply and value chains, providing exhibitors and visitors with more comprehensive networking and business opportunities. To ensure a successful event, the organizing committee is making every effort to curate a dynamic exhibition, featuring professional forums, industry summits, new product launches, and interactive experiences. The exhibition will present a more open, professional, and engaging experience, creating valuable opportunities for industry professionals worldwide. From May 5-8, 2025, China Cycle 2025 looks forward to welcoming global industry partners to Shanghai to witness the future of the bicycle industry together! Company: Shanghai OTOBTB Cultural Development Co.,LtdContact Person: Kira PanEmail: kira.pan@otobtb.comWebsite: http://www.otobtb.comTelephone: 021-32513000-859

NJHealth NMN Ambassador Li Nan Xing Advocates Healthy Ageing

SINGAPORE – March 20, 2025 – (SeaPRwire) – Singaporean actor and cultural icon Li Nan Xing becomes the spokesperson of NJHealth NMN 20000mg. Known for his enduring vitality and charisma, Li Nan Xing’s endorsement underscores the product’s efficacy and aligns with his personal commitment to maintaining vitality as he ages. Li Nan Xing, often called the “King of Caldecott Hill,” is no stranger to the demands of a high-pressure lifestyle. At 60, he remains a beacon of health and resilience, and he credits NJHealth NMN 20000mg for helping him sustain his energy and well-being. “As someone who believes in ageing gracefully while staying active, I was drawn to NJHealth NMN 20000mg for its science-backed benefits,” Li Nan Xing said. “Since incorporating it into my daily routine, I’ve noticed a significant boost in my energy and focus. It’s a game-changer for anyone looking to maintain their vitality and zest for life.” Empowering Singaporeans to Age Smarter – Unlocking the Science of Healthy Ageing NJHealth NMN 20000mg is specially formulated with patented technology to boost NAD⁺ levels to support healthy ageing. Each capsule contains 200mg of NMN with a recommended dose of two capsules daily, or as recommended by healthcare professionals. Manufactured in Japan under Good Manufacturing Practices (GMP), the supplement is rigorously tested by third-party accredited labs for purity and quality. Nicotinamide Mononucleotide (NMN)is a derivative of Vitamin B3 and a precursor of nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for energy and cell function. NAD+ also supports sirtuins, which regulate metabolism and gene health. Since NAD+ declines with age, boosting its levels through NMN supports healthy cell function, increase energy levels, and promotes overall well-being. NJHealth NMN 20000mg is now available online and at Guardian pharmacy outlets in Singapore. Visit www.njhealth.com.sg for product details and testimonials. About NJHealth NJHealth is a new brand under Nin Jiom Group. NJHealth NMN 20000mg healthy ageing supplement is the first product under the new NJHealth brand name. Nin Jiom is an iconic name widely known in Asia. Founded in 1946, the pioneer in modern Chinese medicine is best known for Nin Jiom Pei Pa Koa, a herbal cough syrup trusted for generations for its ability to nourish the lung, eliminate phlegm, relieve cough, soothe the throat and remove heat. The NJHealth brand has been created to showcase another side of the company, one that is more from a scientific and technological perspective.  Singapore is the first market for its NMN 20000mg healthy ageing supplement which comes in 100-capsule bottles. For product enquiries, please contact Luen Wah Medical Co (S) Pte Ltd at +65 6533 9144. For other media enquiries, please contact Mr. Marcus Chang at +65 9479 5657. Media Contact Company: NJHealth Contact: Media Team Website: https://www.njhealth.com.sg/  SOURCE: NJHealth

SAESOL Tech to Spearhead Virtual SCMS Interoperability Testing

Wilmington, DE – March 19, 2025 – (SeaPRwire) – SAESOL Tech is set to lead the interoperability testing of the connected car security certification system, which is being conducted under the support of the U.S. Department of Transportation (USDOT). SAESOL Tech, a company specializing in integrated security solutions for autonomous and connected cars, announced that it will lead the interoperability testing of the connected car security certification system (Virtual SCMS interoperability test) being conducted in OmniAir. SAESOL Tech has been closely participating in the Interoperability Technical Working Group (ITWG) hosted by USDOT. Recently, with the approval of SAESOL Tech’s proposed ‘Virtual SCMS Interoperability Test’, a test is scheduled to be conducted in March under the support of the OmniAir, the global connected car certification industry association. This test is linked to a technical webinar aimed at experts in the V2X field, providing practical preparation opportunities for industry professionals. During the technical webinar held on the 4th March 2025, the testing methods and actual application strategies were presented, attracting significant interest. In particular, this virtual SCMS test is a preparatory step for in-depth security testing at the OmniAir Plugfest to be held in Florida in May 2025, and it is expected to be a crucial opportunity to further enhance the stability and reliability of V2X technology. The OmniAir Plugfest is the largest event in North America where interoperability, compliance, and security testing of technologies related to autonomous and connected vehicles take place. The May event will introduce new sessions, including SCMS (Security Credential Management System) interoperability testing and Identification Certificate testing, drawing significant attention from the industry. SAESOL Tech, which is active as the chair company of the OmniAir Cybersecurity IEEE 1609.2.1 Working Group, plans to conduct interoperability testing between SCMS based on the newly established international V2X security certification standard ‘IEEE 1609.2.1’ at the upcoming PlugFest event. Additionally, they will showcase a demo of their self-developed V2X PKI security certification testing system ‘Test System’ based on ‘IEEE 1609.2.1’, which is the world’s first. Harry Han, CEO of SAESOL Tech, stated, “We plan to continuously expand our collaboration with USDOT to enhance the global interoperability of SCMS technology”. He further mentioned, “In the rapidly changing cybersecurity environment, we will provide more stable and secure V2X solutions to meet the advanced security requirements.” Meanwhile, SAESOL Tech’s SCMS technology is a system that issues and manages highly reliable large-scale security certificates in the V2X communication environment, establishing itself as an essential element for building global autonomous driving infrastructure beyond domestic boundaries. Social Links LinkedIn: https://www.linkedin.com/company/saesoltech/ YouTube: https://www.youtube.com/@SAESOLTECH Media Contact Brand: SAESOL Tech Inc. Contact: YD Jung (Global Business Team Leader) Email: yd.jung@saesol.tech Website: https://www.saesol.tech Address: 1201 North Market Street, Suite 111-L29, Wilmington, DE 19801

Trust Swiftly Launches AI-Fighting Identity Verification Platform with Public Bounty Challenge

Chicago, IL – March 15, 2025 – (SeaPRwire) – Trust Swiftly launched its “Trusted Supervised Remote ID Verification platform” to combat the rising tide of AI-driven fraud. This innovative solution, the first and only of its kind, offers an adaptable approach to identity verification, combining remote and in-person security measures. Trust Swiftly is also launching a public bounty challenge to prove its robustness, inviting experts to test the system’s defenses. Trust Swiftly’s supervised remote identity proofing tackles the growing threat of sophisticated fraud attempts head-on. The platform is exceptionally flexible, incorporating over 20 verification methods, including document verification (with support for thousands of global documents), biometric checks (facial recognition with liveness detection, fingerprint, and voice), and dynamic knowledge-based authentication. It analyzes thousands of data points in real time to rapidly identify and flag potential bad actors and leverages AI agents to expand its coverage. The platform’s unique strength lies in its supervised element. While offering automated verification options, including self-service kiosks for secure locations, it also allows for human oversight when needed. This hybrid approach ensures the highest level of accuracy and security, adapting to various risk levels and use cases. Bounty Challenge for Enhanced Security Trust Swiftly has launched a public bounty challenge to demonstrate its confidence in the platform’s resilience. Security researchers and ethical hackers are invited to attempt to bypass the system’s defenses. This ongoing challenge validates the platform’s current security and contributes to its continuous improvement. The platform offers flexible deployment options, including self-service kiosks for secure locations. Key verification factors of the new system include: Advanced Biometrics: Facial recognition with liveness detection, fingerprint scanning, and voice authentication. Document Verification: Confirming if an ID is real or fake. Datapoint Verification: The system cross-references thousands of datapoints to verify user identities and flag potential fraud. Visit https://trustswiftly.com to learn more about the Trusted Supervised Remote ID Verification platform and the bounty challenge. Request a demo today to see how Trust Swiftly can protect your business from evolving fraud threats. Media Contact Andrew Williams Trust Swiftly Phone: 312-945-0121 Email: andrew@trustswiftly.com

大河證券榮獲2024年香港金融業大獎「最佳證券經紀商」殊榮

Hong Kong - March 10, 2025 - (SeaPRwire) - 大河證券(大河國際資產管理有限公司)在2024年香港金融業大獎(Hong Kong Financial Industry Awards)中榮獲「最佳證券經紀商」(Best Brokerage Firm)大獎,這一成就彰顯了大河證券在專業服務、創新技術與市場影響力方面的卓越表現。本次頒獎典禮於9月26日在香港舉行,匯聚了來自金融、投資及監管領域的重量級嘉賓,共同見證香港金融行業的輝煌時刻。 實力領先 穩居市場前三 作為香港金融市場的重要參與者,大河證券憑藉極具競爭力的手續費、卓越的機構投資服務,以及創新的資金管理模式,在眾多參選機構中脫穎而出,榮獲「最佳證券經紀商」大獎。該獎項旨在表彰在市場業務擴展、交易技術創新、客戶服務與風險管理等方面表現優異的證券公司。 頒獎典禮由香港中國金融協會主辦,涵蓋銀行、投資銀行與券商、資產管理與財富管理、金融科技、ESG與創新金融、保險及公積金等六大領域。此次評選共收到66份參評方案,經過層層篩選,最終有32家機構獲獎。 香港金融業大獎簡介 香港金融業大獎自2005年設立以來,已成為香港金融界最具權威與影響力的獎項之一,旨在表彰金融機構的創新能力與市場競爭力,並推動香港作為國際金融中心的發展。該獎項的評選過程強調公平、公正與透明性,涵蓋以下步驟: 提名與資格審核:由金融機構自主申報或業界推薦候選企業 量化評分:根據市場份額、財務表現、技術創新、客戶體驗等指標進行評估 專家評審:由政府機構、行業協會及投資專家的評審團進行專業評估 最終決選:綜合各方面得分,確定最終獲獎名單 該獎項不僅在香港金融業內擁有高度認受性,亦受到國際市場的廣泛關注。 大河證券的市場優勢與未來展望 此次榮獲「最佳證券經紀商」大獎,是對大河證券多年來專注於機構交易與投資管理領域的肯定。在近年香港金融市場的競爭環境下,大河證券成功躋身香港三大券商之一,與中金公司、中信證券並列2025年最具競爭力的證券公司。 大河證券的核心競爭力包括: IPO市場的領導地位:2024年協助多家企業成功上市,IPO業務排名穩居香港前三 創新交易技術與智能投資:運用AI智能選股、大數據分析與量化交易技術,提升交易與資本管理效率 專注機構投資與私募基金合作:採用「去散戶化」模式,整合市場資金,提供更高效的市場操作環境 國際化發展與亞太市場布局:不僅深耕香港市場,亦積極拓展台灣、東南亞及大灣區,為亞太區投資者提供一站式金融服務 榮譽時刻 持續創新 大河證券的首席投資官在頒獎典禮上表示:「能夠榮獲香港金融業大獎『最佳證券經紀商』,對我們而言是一個極大的肯定。這不僅反映了我們在專業服務、交易技術與市場影響力方面的領先地位,更是對我們未來發展的一種鼓勵。」 他進一步指出:「2025年,我們將繼續致力於創新,擴展全球市場,吸引更多國際投資者,並與更多機構投資者與私募基金合作,提升市場競爭力。我們相信,憑藉我們的專業能力與國際化佈局,大河證券將在未來的金融市場中發揮更加重要的作用。」 大河證券將持續深化技術創新,擴展機構投資業務,並進一步加強風險管理機制,以確保投資者資金安全與市場穩定發展。我們將與全球合作夥伴攜手並進,共同開創香港金融市場的新篇章。 關於大河證券 大河證券成立於2014年,總部位於香港,是一家專注於機構投資、私募基金及高端交易團隊的領先證券公司。憑藉創新交易技術、低手續費與卓越服務,在IPO承銷、量化交易及資本管理領域表現突出。2024年榮獲香港金融業大獎「最佳證券經紀商」,穩居香港市場前三。大河證券致力於推動市場創新,提供專業投資解決方案,並積極拓展亞太市場,助力投資者獲取長期穩定收益。 媒體資料: 公司:大河證券 公司網站:https://daheasset.com 聯系人:Kenny Leung 郵件:info@daheasset.com Facebook: https://www.facebook.com/DaheSecurities

Winvest Group’s IQI Media Gears Up for Q2 Beta Demos of AI & Blockchain-Powered Streaming Distribution Platform

Reno, NV – March 06, 2025 – (SeaPRwire) – Winvest Group Limited (OTCQB: WNLV) (“Winvest”), an investment holding company with diverse media, entertainment, and technology portfolios, is pleased to announce that its subsidiary IQI Media Inc. will be offering beta demos of Launchrr, its proprietary SaaS solution for the film and television industry, in the second quarter of 2025. “Hollywood is facing significant changes, with a notable contraction in production activities,” said Khiow Hui Lim, Founder of IQI Media and Chief Strategy Officer at Winvest. “Shifting consumer behaviors, technological advancements, and the rise of streaming platforms have all played a role. Whether it’s the best time to disrupt Hollywood with a new SaaS product depends on identifying a clear need, delivering a superior solution, and navigating the industry’s complexities. IQI has done just that with Launchrr, which fills a key niche by using AI to optimize content delivery, recommend distribution channels, and predict audience demand.” “As an AI-driven, cloud-based distribution platform designed to revolutionize the streaming ecosystem, Launchrr can help Hollywood innovate through the use of data analytics,” continued Lim. “Beyond that, it can provide secure and transparent residuals using blockchain technology and help both stakeholders and regulators track ownership and royalties. Finally, it can streamline the distribution process in a way that lowers costs and offers efficiencies for everyone involved, from filmmakers to studios.” Typically, the process of submitting content and negotiating deals with multiple streamers is both time-consuming and costly for filmmakers and content creators. An advanced aggregator, Launchrr simplifies the process into a single submission that covers all streamers, dramatically speeding up the time to market while meeting all encoding requirements. From there, Launchrr uses intelligent automation to provide real-time insights and earnings, interactive dashboards, predictive analytics, and blockchain-based security for all intellectual property. “Winvest will be heavily investing in Launchrr’s Phase 2 development,” said Jeffrey Wong, CEO of Winvest. “That’s because we see strong potential for Launchrr based on current industry trends and have several reasons for optimism. For one, Launchrr tackles the industry’s biggest pain point—the streaming wars. It does so by addressing numerous inefficiencies in the current system and shifting the focus to data-driven decision-making. We believe this will result in more informed distribution strategies, not to mention the potential for increased revenue and profitability.” Winvest’s Phase 2 investments in Launchrr will primarily revolve around its new API integration with AI, particularly Large Language Models (LLMs). While most streamers with the exception of a handful continue to use web-based development, Launchrr is preparing for the future by pre-emptively building in API access costs, which include the learning curve involved in utilizing AI models and tailoring the API to fit each streamer, which requires additional coding, testing, and debugging. Other planned expenses include development environments, version control systems, hosting, servers, and specialized AI development tools. “While doubling down on LLMs impacts our development costs, it’s crucial to enhancing Launchrr’s value,” said Lim. “We also feel it supports our desire to align with the Hollywood guilds around the goals of transparency and potentially fairer compensation for all union members associated with a streaming title. Our AI-driven APIs enable accurate and timely performance metrics, plus the ability to identify what audiences are responding to the content and reach them cost-effectively with targeted social advertising. With Launchrr, it’s no longer a guessing game how to find your ideal viewers—or make your content profitable.” About Winvest Group Limited: Headquartered in Reno, Nevada, Winvest is an investment holding company focused on media, entertainment, and technology. Shares in the company are currently traded on the OTC Markets (QB tier) under the stock ticker “WNLV,” with plans to upgrade to Nasdaq and pursue an IPO in the near future. For more information about Winvest and its business developments, please visit http://www.winvestgroup.co. Safe Harbor Statement This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and projections about our industry and involve significant risks and uncertainties that may cause actual results to differ materially. We undertake no obligation to update or revise any forward-looking statements except as required by law. Product/Demos Contact Khiow Hui Lim, Founder of IQI Media & Chief Strategy Officer of Winvest 1055 E. Colorado Blvd., Suite 500, Pasadena, CA 91106 Email: khiowhui@iqimedia.com  Phone: 626-240-4600 https://iqimedia.com/ For Media Inquiries Connie Ting Winvest Group Limited 50 West Liberty Street, Suite 880, Reno NV 89501 Email: connie.ting@winxglobal.com Phone: 775-996-0288

2025年香港十佳券商即將揭曉 大河證券強勢進入前三

Hong Kong - 2025年3月6日 - (SeaPRwire) - 根據最新市場數據與行業報告,2025年香港十佳券商名單即將公布,其中 大河證券(大河國際資產管理有限公司)以卓越的市場表現成功進入前三名,與中金公司及中信證券並列,成為香港市場最具競爭力的證券公司之一。 大河證券強勢崛起 穩居IPO市場前三 在2025年香港IPO市場競爭激烈的環境下,大河證券憑藉高效的投資策略、強勁的市場佈局與創新的金融技術,成功在IPO業務排名穩居前三,與國際及中資龍頭券商比肩。作為香港本土發展最快的證券公司之一,大河證券在機構投資者與私募基金領域的深度耕耘,使其成為市場中不可忽視的重要力量。 2025年香港十佳券商(預測) 中金公司 – 作為頂尖投行,中金公司在香港IPO保薦與承銷業務方面表現突出。 中信證券 – 具有雄厚資本實力,穩居香港IPO市場排名前列。 大河證券 – 近年業務增長迅猛,IPO市場排名穩居前三,機構客戶基礎穩固。 高盛 – 全球頂級投行,在香港市場保持強勁競爭力。 摩根士丹利 – 在香港證券市場佔有重要地位,尤其在IPO承銷方面表現突出。 瑞銀 – 提供全面投資銀行與證券服務,在香港市場保持穩定增長。 花旗環球 – 擁有廣泛業務網絡與強大客戶基礎,在香港市場影響力持續提升。 匯豐 – 以香港最大銀行之一的優勢,穩固其在當地市場的證券業務地位。 富途證券 – 作為領先的互聯網券商,在香港零售市場佔有率不斷提升。 國泰君安 – 中資背景券商中的佼佼者,在香港市場的影響力逐步增強。 市場競爭加劇 大河證券如何脫穎而出? 大河證券在近年來採取獨特的市場策略,專注於機構投資、私募基金合作、量化交易與風險管理,憑藉強勁的技術研發能力與專業投資團隊,使其在眾多競爭對手中脫穎而出。 IPO市場領導地位:大河證券在2024年大幅提升IPO承銷業務,助力多家企業成功上市,進一步鞏固其在資本市場的地位。 量化交易與智能風控:透過大數據分析與AI交易模型,優化資金配置與市場操作,確保穩定收益。 機構客戶與私募基金合作:採用「去散戶化」模式,整合市場資金,提供類似ETF的專業投資方案,確保客戶資金高效運用。 香港與台灣市場雙向佈局:作為少數同時深耕香港與台灣的證券公司,大河證券充分借鑒歐美市場的成熟運營模式,並成功將其引入亞洲市場。 未來展望:持續創新,打造全球頂級券商 隨著2025年金融市場的不斷變革,大河證券將持續推動技術創新,進一步強化在IPO業務、智能交易與風險管理方面的競爭力。未來,公司計劃擴展全球市場,吸引更多國際投資者,並透過與知名機構的合作,將業務版圖延伸至更多高增長市場。 大河證券表示:「我們將持續強化核心競爭力,與市場保持同步成長,為投資者提供更專業、高效的證券交易服務,並致力於成為全球領先的證券公司。」 關於大河證券 大河證券成立於2014年,總部位於香港,是一家專注於機構投資、私募基金及高端交易團隊的領先證券公司。憑藉創新交易技術、低手續費與卓越服務,在IPO承銷、量化交易及資本管理領域表現突出。2024年榮獲香港金融業大獎「最佳證券經紀商」,穩居香港市場前三。大河證券致力於推動市場創新,提供專業投資解決方案,並積極拓展亞太市場,助力投資者獲取長期穩定收益。 媒體資料 公司:大河證券(大河國際資產管理有限公司) 公司網站:https://daheasset.com/ 聯系人:Kenny Leung 郵件:info@daheasset.com Facebook : https://www.facebook.com/DaheSecurities